#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fms-like tyrosine kinase 3 positive Congenital aplastic anaemia Congenital absence of bile ducts Malignant neoplasm of choroid Adult T-cell lymphoma/leukaemia refractory Bladder cancer Hydrocephalus Hypophosphatasia Pleural mesothelioma malignant Acute graft versus host disease Pericarditis Hepatitis D Cytomegalovirus infection Spina bifida Myocarditis More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Diagnostics Angiosarcoma non-metastatic – Trials in Disease Mastocytosis – Basic Information Angiosarcoma metastatic – Treatment Lymphangioma – Life with Disease Osteosarcoma metastatic – Treatment Waldenstrom’s macroglobulinaemia refractory – Diagnostics Primary mediastinal large B-cell lymphoma – Diagnostics Malignant fibrous histiocytoma – Life with Disease Focal segmental glomerulosclerosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pravastatin Sodium Briquilimab AZD0516 Nilutamide Lamivudine Bbp-398 ULTEVURSEN TTX-381 Tepotinib Xp-Dc+Tl+Klh VRDN-003 LINAPRAZAN GLURATE Tradipitant SIGVOTATUG VEDOTIN Gen3017 Cd7-Cart01 Quercus Robur Pollen Extract Mocravimod Oteracil Sodium Picosulfate More therapies…

    Learn about Your Condition

    K-ras gene mutation Relapsing multiple sclerosis Bile acid synthesis disorder Nephroblastoma Marginal zone lymphoma Pelvic venous thrombosis Bronchopulmonary dysplasia Non-obstructive cardiomyopathy Pelizaeus-Merzbacher disease Arterial disorder Osteomyelitis acute Sleep disorder Pemphigoid Ebola disease Exudative retinopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Autologous Microfat and Platelet-Rich Plasma Injection Compared to Wrist Denervation in Patients with Radiocarpal Osteoarthritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Autologous Microfat
    • Platelet Concentrate
    France

  • Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Oesophageal carcinoma
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Azd0901
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    Poland Spain

  • Study of Pembrolizumab and Lenvatinib for Patients with Resectable Non-Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    Austria

  • Study on the Effectiveness of Sphenopalatine Ganglion Block vs. Scalp Block in Patients Undergoing Craniotomy for Supratentorial Mass Using Levobupivacaine and Drug Combination

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cisatracurium Besilate
    • Etoricoxib
    • Levobupivacaine
    Belgium

  • Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

    Recruiting

    3 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Givinostat
    Belgium France Germany Italy The Netherlands Spain

  • Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zongertinib
    Belgium France Germany Italy The Netherlands Norway +1
Previous Page
1 … 360 361 362 363 364 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!